Multiple Dose Study of MK-6024 in Healthy Japanese Participants
Phase 1
- Conditions
- onalcoholic steatohepatitis
- Registration Number
- JPRN-jRCT2031210703
- Lead Sponsor
- Yoshiyuki Tanaka
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
Healthy male aged 20 to 65 years old with BMI 23 to 40 kg/m2
Exclusion Criteria
Has a history of clinically significant abnormalities or diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method AEs and AEs leading to discontinuation
- Secondary Outcome Measures
Name Time Method Following serum PK parameters<br>-Following 4th, 8th, 12th and last (16th) doses: Tmax, Cmax, AUC0-tau<br>-Following 16th dose: t1/2, CL/F, Vz/F <br>-Following 3rd, 4th, 7th, 8th, 11th to 16th doses: Ctrough